Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-09-16

LivaNova PLC (LIVN)

CEO Vladimir Makatsaria was paid $8,047,217 in fiscal year 2025, ↓ down 17.1% from fiscal year 2024, the 47th percentile of its disclosed peer group (SEC filing 0001104659-26-050937 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$8,047,217 ↓
Vladimir Makatsaria total, FY2025
47th
CEO pay percentile vs peers
101:1
CEO-to-median pay ratio
99%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Vladimir Makatsaria (Chief Executive Officer), FY2025 total compensation $8,047,217 (base salary $956,115) [exec_comp, SEC accession 0001104659-26-050937, filed 2026-04-29]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

LIVN's next annual pay disclosure, estimated April 28, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Vladimir Makatsaria$956,115$0$4,303,092$1,374,999$1,287,656$0$125,355$8,047,217
Chief Executive Officer
Alex Shvartsburg587,76501,329,999424,990467,767065,3782,875,899
Chief Financial Officer
Ahmet Tezel564,80801,251,785399,984449,497053,0002,719,074
Senior Vice President, Chief Innovation Officer
Natalia Kozmina496,63459,2321,282,238249,986393,8670139,3152,621,272
Chief Human Resources Officer
Michael Hutchinson541,63601,095,282349,991431,056053,8682,471,833
Former Senior Vice President, Chief Legal Officer and Company Secretary

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Vladimir Makatsaria$8,047,217$9,710,672—↓ −1,663,455
Alex Shvartsburg2,875,8992,829,6892,771,180↑ +46,210
Ahmet Tezel2,719,0742,773,543—↓ −54,469
Natalia Kozmina2,621,272———
Michael Hutchinson2,471,8332,406,8742,072,351↑ +64,959

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read LivaNova PLC's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper LIVN reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

Get the LivaNova PLC Peer Teardown Report

$8,047,217 Vladimir Makatsaria total, FY2025

$199

The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.

Data as of September 16, 2026 · Source: 0001104659-26-050937 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Reports for LIVN

Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:

Executive Compensation ReportThe free page is the headline figures. The report is every award, peer and vote combined into one document you can hand to a committee.$1,500 →Reverse Peer AnalysisThe free page is the one line. The analysis reads every company that names this one in its own peer group.$299 →Peer Teardown ReportThe free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.$199 →
LIVNon Velarion Intel, free → The platform reading of this company, beside the same data as a subscription.

Order LIVN

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

How we handle your data → Privacy

Companies that benchmark against LIVN
17 companies name LIVN as a compensation peer

Each company listed discloses LIVN in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named LIVN in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Get the LivaNova PLC Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2025 total
Ahmet TezelSVP$2,719,074
Alex ShvartsburgCFO$2,875,899
Michael HutchinsonGeneral Counsel$2,471,833
Natalia KozminaChief Human Resources Officer$2,621,272
Vladimir MakatsariaCEO$8,047,217
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Brooke StoryIndependent Director$259,588
Donald ZurbayIndependent Director$169,387
Francesco BianchiIndependent Director$274,588
J. Christopher BarryIndependent Director$274,588
Jette Nygaard-AndersenIndependent Director—
Peter WilverIndependent Director$274,588
Sharon O'KaneIndependent Director$270,484
Stacy Enxing SengDirector$270,484
Susan PodlogarDirector$259,588
Todd SchermerhornIndependent Director$280,484
William KozyChair of the Board$400,485
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Francesco BianchiDirector2026-05-26D1,800$76$136,350CommonForm 4 ↗
Ahmet TezelChief Innovation Officer2026-06-15A2,96500CommonForm 4 ↗
Francesco BianchiDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
Seng Stacy EnxingDirector2026-06-15A4,04200CommonForm 4 ↗
William KozyDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
William KozyDirector2026-06-15D5,68100Derivative, Class A CommonForm 4 ↗
J. Christopher BarryDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
Francesco BianchiDirector2026-06-15D1,2008096,228CommonForm 4 ↗
Todd SchermerhornDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
Todd SchermerhornDirector2026-06-15A4,04200CommonForm 4 ↗
Peter WilverDirector2026-06-15D4,04200Derivative, Class A CommonForm 4 ↗
Ahmet TezelChief Innovation Officer2026-06-15D1,0328082,250CommonForm 4 ↗
Jette Nygaard-AndersenDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
Ahmet TezelChief Innovation Officer2026-06-15D2,96500Derivative, Class A CommonForm 4 ↗
Susan PodlogarDirector2026-06-15D4868038,734CommonForm 4 ↗
Peter WilverDirector2026-06-15D4868038,734CommonForm 4 ↗
Susan PodlogarDirector2026-06-15A4,04200CommonForm 4 ↗
Seng Stacy EnxingDirector2026-06-15D4868038,734CommonForm 4 ↗
Donald ZurbayDirector2026-06-15D2,56000Derivative, Class A CommonForm 4 ↗
Brooke StoryDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
Peter WilverDirector2026-06-15A4,04200CommonForm 4 ↗
J. Christopher BarryDirector2026-06-15D4,04200Derivative, Class A CommonForm 4 ↗
J. Christopher BarryDirector2026-06-15A4,04200CommonForm 4 ↗
Francesco BianchiDirector2026-06-15D4868038,734CommonForm 4 ↗
Peter WilverDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
Donald ZurbayDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
Donald ZurbayDirector2026-06-15D3088024,548CommonForm 4 ↗
Donald ZurbayDirector2026-06-15A2,56000CommonForm 4 ↗
Brooke StoryDirector2026-06-15D4,04200Derivative, Class A CommonForm 4 ↗
Brooke StoryDirector2026-06-15A4,04200CommonForm 4 ↗
Seng Stacy EnxingDirector2026-06-15D4,04200Derivative, Class A CommonForm 4 ↗
William KozyDirector2026-06-15A5,68100CommonForm 4 ↗
J. Christopher BarryDirector2026-06-15D4868038,734CommonForm 4 ↗
Susan PodlogarDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
Susan PodlogarDirector2026-06-15D4,04200Derivative, Class A CommonForm 4 ↗
Francesco BianchiDirector2026-06-15D4,04200Derivative, Class A CommonForm 4 ↗
Francesco BianchiDirector2026-06-15A4,04200CommonForm 4 ↗
Todd SchermerhornDirector2026-06-15D4,04200Derivative, Class A CommonForm 4 ↗
Todd SchermerhornDirector2026-06-15D4868038,734CommonForm 4 ↗
Brooke StoryDirector2026-06-15D4868038,734CommonForm 4 ↗
Seng Stacy EnxingDirector2026-06-15A2,38300Derivative, Class A CommonForm 4 ↗
William KozyDirector2026-06-15D6828054,355CommonForm 4 ↗
Ahmet TezelChief Innovation Officer2026-08-11D12,69200Derivative, Class A CommonForm 4 ↗
Ahmet TezelChief Innovation Officer2026-08-11D8,58978668,740CommonForm 4 ↗
Ahmet TezelChief Innovation Officer2026-08-11A12,69253668,615CommonForm 4 ↗
Ahmet TezelChief Innovation Officer2026-08-11D2,67578207,942CommonForm 4 ↗
Ahmet TezelChief Innovation Officer2026-08-11D1,42878111,184CommonForm 4 ↗
Francesco BianchiDirector2026-08-31D1,65080131,538CommonForm 4 ↗
Brooke StoryDirector2026-09-04D2,30081187,270CommonForm 4 ↗
Francesco BianchiDirector2026-09-10D3,50078273,032CommonForm 4 ↗
Anne M. LiddyChief Legal Officer2026-09-15A6,29100Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Vladimir MakatsariaPSU2025-03-30—35,139—70,278$1,553,153
Alex ShvartsburgPSU2025-03-30—10,861—21,722480,056
Natalia KozminaPSU2025-03-30—3,194—6,388124,981
Natalia KozminaRSU2025-03-30——6,388—12,776
Ahmet TezelPSU2025-03-30—10,222—20,444451,812
Vladimir MakatsariaOPTION2025-03-30——76,927—1,374,999
Alex ShvartsburgRSU2025-03-30——10,861—424,991
Alex ShvartsburgOPTION2025-03-30——23,777—424,990
Vladimir MakatsariaRSU2025-03-30——35,139—1,374,989
Ahmet TezelOPTION2025-03-30——22,378—399,984
Alex ShvartsburgPSU2025-03-30—5,430—10,860212,476
Ahmet TezelPSU2025-03-30—5,111—10,222199,993
Vladimir MakatsariaPSU2025-03-30—17,569—35,138687,475
Ahmet TezelRSU2025-03-30——10,222—399,987
Alex ShvartsburgPSU2025-03-30—5,430—10,860212,476
Vladimir MakatsariaPSU2025-03-30—17,569—35,138687,475
Ahmet TezelPSU2025-03-30—5,111—10,222199,993
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Vladimir Makatsaria$1,374,989$2,928,103$1,374,99951.6%
Alex Shvartsburg424,991905,008424,99051.6%
Natalia Kozmina12,776124,981090.7%
Ahmet Tezel399,987851,798399,98451.6%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Michael HutchinsonRSU8,944—$550,324
Michael HutchinsonRSU2,253—138,627
Vladimir MakatsariaPSU11,954—735,530
Vladimir MakatsariaPSU23,909—1,471,121
Vladimir MakatsariaRSU35,139—2,162,103
Vladimir MakatsariaPSU35,139—2,162,103
Ahmet TezelRSU10,222—628,960
Vladimir MakatsariaRSU27,986—1,721,979
Ahmet TezelPSU10,222—628,960
Vladimir MakatsariaPSU17,569—1,081,021
Natalia KozminaRSU12,777—786,169
Michael HutchinsonPSU5,809—357,428
Alex ShvartsburgRSU10,861—668,277
Alex ShvartsburgPSU10,861—668,277
Alex ShvartsburgOption2,12882.04—
Alex ShvartsburgPSU10,769—662,617
Michael HutchinsonPSU8,944—550,324
Ahmet TezelRSU8,896—547,371
Alex ShvartsburgPSU7,150—439,940
Alex ShvartsburgRSU4,728—290,914
Natalia KozminaPSU3,194—196,527
Ahmet TezelPSU7,118—437,971
Michael HutchinsonPSU6,730—414,097
Alex ShvartsburgRSU5,362—329,924
Natalia KozminaRSU6,388—393,054
Natalia KozminaPSU6,388—393,054
Alex ShvartsburgPSU3,575—219,970
Alex ShvartsburgPSU5,768—354,905
Alex ShvartsburgPSU5,612—345,306
Michael HutchinsonOption6,27742.71—
Alex ShvartsburgPSU5,430—334,108
Ahmet TezelPSU5,111—314,480
Michael HutchinsonPSU4,472—275,162
Michael HutchinsonPSU2,904—178,683
Michael HutchinsonRSU4,356—268,025
Michael HutchinsonPSU3,605—221,816
Ahmet TezelPSU3,559—218,985
Michael HutchinsonPSU3,507—215,786
Michael HutchinsonRSU2,955—181,821
Alex ShvartsburgRSU914—56,238
Vladimir MakatsariaOption61,18255.94—
Ahmet TezelOption22,37839.13—
Vladimir MakatsariaOption76,92739.13—
Alex ShvartsburgOption10,04442.71—
Alex ShvartsburgOption11,72355.94—
Alex ShvartsburgOption23,77739.13—
Ahmet TezelOption19,03652.68—
Natalia KozminaOption13,98639.13—
Michael HutchinsonOption9,52555.94—
Michael HutchinsonOption19,58139.13—
05

Incentive-plan design — the Compensation Discussion & Analysis

LivaNova uses U.S. pay levels and structures as its primary reference point to establish competitive compensation levels for the Company’s executive officers, while also considering compensation and benefit trends and practices of the countries where the Company hires its executive officers.

CEO STI target (% of salary)110%
CEO LTI target (% of salary)—
Independent consultantPearl Meyer
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-1049,311,078499,53618,22599%Passed
20252025-06-1143,157,2811,352,69114,35196.96%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-1099%a
20252025-06-1196.96%b

a. Approved under the standard stated in the filing — “Abstentions Under English law, an abstention is not a vote in law and will not be counted in the calculation of the proportion of votes "for" or "against" the resolution.”.

b. Approved under the standard stated in the filing — “Abstentions Under English law, an abstention is not a vote in law and will not be counted in the calculation of the proportion of votes "for" or "against" the resolution.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)101 : 1
CEO total compensation$8,047,217
Median employee compensation$79,459
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
William KozyIndependent · Board Chair$140,522$259,963$0$0$0$400,485
Todd SchermerhornIndependent · Audit and Compliance (Chair)95,522184,962000280,484
J. Christopher BarryIndependent · Audit and Compliance · Nominating and Corporate Governance89,626184,962000274,588
Francesco BianchiIndependent · Audit and Compliance · Compensation and Human Capital Management89,626184,962000274,588
Peter WilverIndependent · Audit and Compliance · Compensation and Human Capital Management89,626184,962000274,588
Sharon O'KaneIndependent · Nominating and Corporate Governance85,522184,962000270,484
Stacy Enxing SengCompensation and Human Capital Management (Chair)85,522184,962000270,484
Brooke StoryIndependent · Nominating and Corporate Governance74,626184,962000259,588
Susan PodlogarCompensation and Human Capital Management · Nominating and Corporate Governance74,626184,962000259,588
Donald ZurbayIndependent · Audit and Compliance · Newly elected27,486141,901000169,387
Jette Nygaard-AndersenIndependent · Newly elected000000
Vladimir MakatsariaEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$70,000
Annual equity retainer$185,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)30,000 / 20,000 / 20,000
Stock ownership guideline$350,000
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$852,704
Equity awards (grant-date value)$1,881,560
All other compensation$0
Total cost of the board$2,734,264

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies LivaNova PLC names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including LivaNova PLC.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Masimo Corporation2025Catherine Szyman$850,048$16,388,693$1,399,998$1,130,000$19,797,140
2Merit Medical Systems, Inc.2025Fred Lampropoulos1,890,0009,313,60601,882,89413,755,143
3Haemonetics Corporation2026Christopher Simon1,100,0087,561,9871,504,9681,834,25012,044,701
4Nevro Corp.(2)2023Kevin Thornal515,62510,080,1730402,75011,453,548
5Avanos Medical, Inc.2025David Pacitti751,7057,000,00001,148,6679,469,803
6Integra LifeSciences Holdings Corporation2025Mojdeh Poul1,009,6165,219,8682,250,011174,5639,375,551
7Enovis Corporation2025Damien McDonald634,6157,262,6440812,7499,242,161
8Integer Holdings Corporation2025Joseph Dziedzic1,235,0005,999,95101,323,7668,671,332
9LivaNova PLC2025Vladimir Makatsaria956,1154,303,0921,374,9991,287,6568,047,217
10Inspire Medical Systems, Inc.2025Timothy Herbert750,5725,999,6550961,5577,711,784
11CONMED Corporation2025Patrick Beyer891,1002,499,9712,499,9771,129,4697,634,873
12Tandem Diabetes Care, Inc.2025John Sheridan790,5835,367,7960674,0906,858,503
13ICU Medical, Inc.2025Vivek Jain775,0004,500,02301,162,5006,452,042
14Inari Medical, Inc.(1)2023Andrew Hykes700,0002,606,744937,488826,0005,083,365
15Globus Medical, Inc.2025Keith Pfeil479,46702,982,347783,0004,400,159
16Penumbra, Inc.(3)2025Adam Elsesser850,000000851,621

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
LivaNova PLC122.4%PSU 50 · RSU 25 · Options 25NoPearl Meyer
Avanos Medical, Inc.139%PSU 50 · RSU 25 · Options 25NoMeridian Compensation Partners
CONMED Corporation126.8%Options 50 · PSU 50Yes — rTSRCompensia, Inc.
Enovis Corporation92.2%PSU 50 · RSU 50Yes — Relative TSR vs. S&P 500 Health Care Equipment Select Industry IndexFW Cook
Globus Medical, Inc.102%Options 100not disclosedFW Cook
Haemonetics Corporation133.4%PSU 60 · RSU 20 · Options 20Yes — Relative Total Shareholder Return (rTSR)Pearl Meyer & Partners, LLC
ICU Medical, Inc.150%PSU 50 · RSU 50NoCompensia
Inari Medical, Inc.(1)118%RSU 75 · Option 25not disclosedFW Cook
Inspire Medical Systems, Inc.111.4%PSU 50 · RSU 50NoAon
Integer Holdings Corporation85.75%PSU 66 · RSU 34Yes — Relative TSR versus peer groupFW Cook
Integra LifeSciences Holdings Corporation40%PSU 50 · Options 25 · RSU 25NoWTW
Masimo Corporationnot disclosednot disclosednot disclosedFW Cook
Merit Medical Systems, Inc.124.53%PSU 60 · RSU 40Yes — Relative Total Shareholder Return (rTSR)Pearl Meyer & Partners, LLC
Nevro Corp.(2)53.7%not disclosedNoAon
Penumbra, Inc.(3)not disclosednot disclosedNoCompensia
Tandem Diabetes Care, Inc.87%PSU 50 · RSU 50Yes — TSR performance compared to the Russell 3000 index in the three-year period between 2025 and 2027WTW

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at LivaNova PLC in fiscal 2025?
As disclosed, Vladimir Makatsaria (Chief Executive Officer) was the highest-paid executive at LivaNova PLC in fiscal 2025, with total compensation of $8,047,217.
How does LivaNova PLC's chief executive pay compare to its disclosed peer group?
As disclosed, Vladimir Makatsaria's total compensation ranked at the 47th percentile of LivaNova PLC's disclosed peer group.
What is LivaNova PLC's CEO-to-median employee pay ratio?
As disclosed, LivaNova PLC's CEO-to-median employee pay ratio was 101:1.
How did shareholders vote on LivaNova PLC's executive compensation?
As disclosed, 99% of shareholders supported LivaNova PLC's executive compensation in the latest say-on-pay vote.
How much does LivaNova PLC spend in total on board compensation for fiscal 2025?
As disclosed, LivaNova PLC reported total board compensation of $2,734,264 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Vladimir MakatsariaDEF 14A2026-04-290001104659-26-050937Section “Compensation Tables”. As printed: 8,047,217. Filing ↗machine: t117 · r3 · c50 · span 1095329–1095338
2Section 01, Alex ShvartsburgDEF 14A2026-04-290001104659-26-050937Section “COMPENSATION TABLES”. As printed: 2,875,899. Filing ↗machine: t117 · r6 · c50 · span 1110672–1110681
3Section 01, Ahmet TezelDEF 14A2026-04-290001104659-26-050937Section “COMPENSATION TABLES”. As printed: 2,719,074. Filing ↗machine: t117 · r10 · c50 · span 1133140–1133149
4Section 01, Natalia KozminaDEF 14A2026-04-290001104659-26-050937Section “COMPENSATION TABLES”. As printed: 2,621,272. Filing ↗machine: t117 · r13 · c50 · span 1148585–1148594
5Section 01, Michael HutchinsonDEF 14A2026-04-290001104659-26-050937Section “COMPENSATION TABLES”. As printed: 2,471,833. Filing ↗machine: t117 · r15 · c50 · span 1156942–1156951
6Section 03, Vladimir Makatsaria PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1319555–1319564
7Section 03, Alex Shvartsburg PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1385825–1385832
8Section 03, Natalia Kozmina PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗
9Section 03, Natalia Kozmina RSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1513540–1513546
10Section 03, Ahmet Tezel PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1452084–1452091
11Section 03, Vladimir Makatsaria OPTIONDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1340965–1340974
12Section 03, Alex Shvartsburg RSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1396523–1396530
13Section 03, Alex Shvartsburg OPTIONDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1407231–1407238
14Section 03, Vladimir Makatsaria RSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1330255–1330264
15Section 03, Ahmet Tezel OPTIONDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1473490–1473497
16Section 03, Alex Shvartsburg PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗
17Section 03, Ahmet Tezel PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗
18Section 03, Vladimir Makatsaria PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1297359–1297366
19Section 03, Ahmet Tezel RSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1462782–1462789
20Section 03, Alex Shvartsburg PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1374727–1374734
21Section 03, Vladimir Makatsaria PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1308457–1308464
22Section 03, Ahmet Tezel PSUDEF 14A1900-01-010001104659-26-050937Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1440986–1440993
23Section 07, pay ratioDEF 14A2026-04-290001104659-26-050937Section “CEO Pay Ratio”. As printed: 101 : 1. Filing ↗machine: span 2437639–2437642
24Section 08, William KozyDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 400,485. Filing ↗machine: t69 · r1 · c22 · span 496563–496570
25Section 08, Todd SchermerhornDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 280,484. Filing ↗machine: t69 · r7 · c22 · span 519464–519471
26Section 08, J. Christopher BarryDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 274,588. Filing ↗machine: t69 · r2 · c22 · span 500530–500537
27Section 08, Francesco BianchiDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 274,588. Filing ↗machine: t69 · r3 · c22 · span 504196–504203
28Section 08, Peter WilverDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 274,588. Filing ↗machine: t69 · r9 · c22 · span 527084–527091
29Section 08, Sharon O'KaneDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 270,484. Filing ↗machine: t69 · r5 · c22 · span 511837–511844
30Section 08, Stacy Enxing SengDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 270,484. Filing ↗machine: t69 · r4 · c22 · span 508160–508167
31Section 08, Brooke StoryDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 259,588. Filing ↗machine: t69 · r8 · c22 · span 523423–523430
32Section 08, Susan PodlogarDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 259,588. Filing ↗machine: t69 · r6 · c22 · span 515798–515805
33Section 08, Donald ZurbayDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 169,387. Filing ↗machine: t69 · r10 · c22 · span 531159–531166
34Section 08, Jette Nygaard-AndersenDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 0. Filing ↗
35Section 08, Vladimir MakatsariaDEF 14A2026-04-290001104659-26-050937Section “Director Compensation”. As printed: 0. Filing ↗
36Section 02, Francesco Bianchi 2026-05-26Form 42026-05-270001639691-26-000040Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Ahmet Tezel 2026-06-15Form 42026-06-170001639691-26-000072Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Francesco Bianchi 2026-06-15Form 42026-06-170001639691-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Seng Stacy Enxing 2026-06-15Form 42026-06-170001639691-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, William Kozy 2026-06-15Form 42026-06-170001639691-26-000070Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, William Kozy 2026-06-15Form 42026-06-170001639691-26-000070Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, J. Christopher Barry 2026-06-15Form 42026-06-170001639691-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Francesco Bianchi 2026-06-15Form 42026-06-170001639691-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Todd Schermerhorn 2026-06-15Form 42026-06-170001639691-26-000076Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Todd Schermerhorn 2026-06-15Form 42026-06-170001639691-26-000076Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Peter Wilver 2026-06-15Form 42026-06-170001639691-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Ahmet Tezel 2026-06-15Form 42026-06-170001639691-26-000072Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Jette Nygaard-Andersen 2026-06-15Form 42026-06-170001639691-26-000071Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Ahmet Tezel 2026-06-15Form 42026-06-170001639691-26-000072Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Susan Podlogar 2026-06-15Form 42026-06-170001639691-26-000074Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Peter Wilver 2026-06-15Form 42026-06-170001639691-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Susan Podlogar 2026-06-15Form 42026-06-170001639691-26-000074Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Seng Stacy Enxing 2026-06-15Form 42026-06-170001639691-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Donald Zurbay 2026-06-15Form 42026-06-170001639691-26-000067Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Brooke Story 2026-06-15Form 42026-06-170001639691-26-000068Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Peter Wilver 2026-06-15Form 42026-06-170001639691-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, J. Christopher Barry 2026-06-15Form 42026-06-170001639691-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, J. Christopher Barry 2026-06-15Form 42026-06-170001639691-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Francesco Bianchi 2026-06-15Form 42026-06-170001639691-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Peter Wilver 2026-06-15Form 42026-06-170001639691-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Donald Zurbay 2026-06-15Form 42026-06-170001639691-26-000067Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Donald Zurbay 2026-06-15Form 42026-06-170001639691-26-000067Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Donald Zurbay 2026-06-15Form 42026-06-170001639691-26-000067Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Brooke Story 2026-06-15Form 42026-06-170001639691-26-000068Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Brooke Story 2026-06-15Form 42026-06-170001639691-26-000068Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Seng Stacy Enxing 2026-06-15Form 42026-06-170001639691-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, William Kozy 2026-06-15Form 42026-06-170001639691-26-000070Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, J. Christopher Barry 2026-06-15Form 42026-06-170001639691-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Susan Podlogar 2026-06-15Form 42026-06-170001639691-26-000074Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Susan Podlogar 2026-06-15Form 42026-06-170001639691-26-000074Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Francesco Bianchi 2026-06-15Form 42026-06-170001639691-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Francesco Bianchi 2026-06-15Form 42026-06-170001639691-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Todd Schermerhorn 2026-06-15Form 42026-06-170001639691-26-000076Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Todd Schermerhorn 2026-06-15Form 42026-06-170001639691-26-000076Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Brooke Story 2026-06-15Form 42026-06-170001639691-26-000068Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Seng Stacy Enxing 2026-06-15Form 42026-06-170001639691-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, William Kozy 2026-06-15Form 42026-06-170001639691-26-000070Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Ahmet Tezel 2026-08-11Form 42026-08-130001639691-26-000094Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Ahmet Tezel 2026-08-11Form 42026-08-130001639691-26-000094Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Ahmet Tezel 2026-08-11Form 42026-08-130001639691-26-000094Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Ahmet Tezel 2026-08-11Form 42026-08-130001639691-26-000094Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Ahmet Tezel 2026-08-11Form 42026-08-130001639691-26-000094Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Francesco Bianchi 2026-08-31Form 42026-09-020001639691-26-000100Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Brooke Story 2026-09-04Form 42026-09-080001639691-26-000102Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Francesco Bianchi 2026-09-10Form 42026-09-140001639691-26-000104Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Anne M. Liddy 2026-09-15Form 42026-09-160001639691-26-000106Insider equity transaction reported since the proxy statement. Filing ↗
87Section 06, 2026 voteForm 8-K2026-06-110001639691-26-000053Item 5.07 · say-on-pay result. As reported: 99% (votes for as printed: 49,311,078). Filing ↗
88Section 06, 2025 voteForm 8-K2025-06-110001639691-25-000052Item 5.07 · say-on-pay result. As reported: 96.96% (votes for as printed: 43,157,281). Filing ↗
89Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
90Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
91Section 09b board cost (computed)Computed——Cash 852,704 + equity 1,881,560 + all other 0 = 2,734,264, summed across the director compensation table rows.machine: formula: Σ = 2,734,264
92Masimo Corporation, Section 10b CEO total10-K2026-05-010001104659-26-054180CEO total compensation as printed in Masimo Corporation's own proxy. As printed: 19,797,140. Filing ↗machine: r4 · c22 · span 477159–477169
93Merit Medical Systems, Inc., Section 10b CEO totalDEF 14A2026-03-310000856982-26-000013CEO total compensation as printed in Merit Medical Systems, Inc.'s own proxy. As printed: 13,755,143. Filing ↗machine: r21 · c8 · span 1277869–1277879
94Haemonetics Corporation, Section 10b CEO totalDEF 14A2026-06-090000313143-26-000074CEO total compensation as printed in Haemonetics Corporation's own proxy. As printed: 12,044,701. Filing ↗machine: span 718173–718183
95Nevro Corp.(2), Section 10b CEO totalDEF 14A2024-04-120000950170-24-044100CEO total compensation as printed in Nevro Corp.(2)'s own proxy. As printed: 11,453,548. Filing ↗machine: r2 · c16 · span 631983–631993
96Avanos Medical, Inc., Section 10b CEO totalDEF 14A2026-03-120001104659-26-027106CEO total compensation as printed in Avanos Medical, Inc.'s own proxy. As printed: 9,469,803. Filing ↗machine: r1 · c53 · span 1674377–1674386
97Integra LifeSciences Holdings Corporation, Section 10b CEO totalDEF 14A2026-04-060000917520-26-000015CEO total compensation as printed in Integra LifeSciences Holdings Corporation's own proxy. As printed: 9,375,551. Filing ↗machine: r2 · c30 · span 880204–880213
98Enovis Corporation, Section 10b CEO totalDEF 14A2026-04-060001493152-26-015302CEO total compensation as printed in Enovis Corporation's own proxy. As printed: 9,242,161. Filing ↗machine: r1 · c37 · span 876874–876883
99Integer Holdings Corporation, Section 10b CEO totalDEF 14A2026-04-060001114483-26-000009CEO total compensation as printed in Integer Holdings Corporation's own proxy. As printed: 8,671,332. Filing ↗machine: t48 · r17 · c21 · span 738226–738235
100LivaNova PLC (subject), Section 10b CEO totalDEF 14A2026-04-290001104659-26-050937CEO total compensation as printed in LivaNova PLC's own proxy. As printed: 8,047,217. Filing ↗machine: t117 · r3 · c50 · span 1095329–1095338
101Inspire Medical Systems, Inc., Section 10b CEO totalDEF 14A2026-03-200001140361-26-010490CEO total compensation as printed in Inspire Medical Systems, Inc.'s own proxy. As printed: 7,711,784. Filing ↗machine: r2 · c25 · span 1164868–1164877
102CONMED Corporation, Section 10b CEO totalDEF 14A2026-04-070000816956-26-000047CEO total compensation as printed in CONMED Corporation's own proxy. As printed: 7,634,873. Filing ↗machine: r3 · c27 · span 1186564–1186573
103Tandem Diabetes Care, Inc., Section 10b CEO totalDEF 14A2026-04-070001438133-26-000034CEO total compensation as printed in Tandem Diabetes Care, Inc.'s own proxy. As printed: 6,858,503. Filing ↗machine: r3 · c27 · span 866963–866972
104ICU Medical, Inc., Section 10b CEO totalDEF 14A2026-04-020000883984-26-000019CEO total compensation as printed in ICU Medical, Inc.'s own proxy. As printed: 6,452,042. Filing ↗machine: r2 · c24 · span 432290–432299
105Inari Medical, Inc.(1), Section 10b CEO totalDEF 14A2024-03-130001193125-24-066805CEO total compensation as printed in Inari Medical, Inc.(1)'s own proxy. As printed: 5,083,365. Filing ↗machine: r2 · c31 · span 454508–454517
106Globus Medical, Inc., Section 10b CEO totalDEF 14A2026-04-240001628280-26-027196CEO total compensation as printed in Globus Medical, Inc.'s own proxy. As printed: 4,400,159. Filing ↗machine: r5 · c21 · span 344690–344699
107Penumbra, Inc.(3), Section 10b CEO totalDEF 14A2026-04-290001321732-26-000010CEO total compensation as printed in Penumbra, Inc.(3)'s own proxy. As printed: 851,621. Filing ↗machine: span 424797–424804
108Section 10a, Integra LifeSciences Holdings Corporation reciprocityDEF 14A—0000917520-26-000015Integra LifeSciences Holdings Corporation names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
109Section 10a, CONMED Corporation reciprocityDEF 14A—0000816956-26-000047CONMED Corporation names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
110Section 10a, Masimo Corporation reciprocityDEF 14A—0001104659-26-054180Masimo Corporation names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
111Section 10a, Haemonetics Corporation reciprocityDEF 14A—0000313143-26-000074Haemonetics Corporation names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
112Section 10a, Merit Medical Systems, Inc. reciprocityDEF 14A—0000856982-26-000013Merit Medical Systems, Inc. names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
113Section 10a, Inari Medical, Inc.(1) reciprocityDEF 14A—0001193125-24-066805Inari Medical, Inc.(1) names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
114Section 10a, Penumbra, Inc.(3) reciprocityDEF 14A—0001321732-26-000010Penumbra, Inc.(3) names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
115Section 10a, Integer Holdings Corporation reciprocityDEF 14A—0001114483-26-000009Integer Holdings Corporation names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
116Section 10a, Tandem Diabetes Care, Inc. reciprocityDEF 14A—0001438133-26-000034Tandem Diabetes Care, Inc. names LivaNova PLC in its own disclosed peer group (read from its most recent proxy). Filing ↗
117Section 10a, ICU Medical, Inc. reciprocityDEF 14A—0000883984-26-000019ICU Medical, Inc.'s most recent proxy was read; its disclosed peer group does not include LivaNova PLC. Filing ↗
118Section 10a, Inspire Medical Systems, Inc. reciprocityDEF 14A—0001140361-26-010490Inspire Medical Systems, Inc.'s most recent proxy was read; its disclosed peer group does not include LivaNova PLC. Filing ↗
119Section 10a, Avanos Medical, Inc. reciprocityDEF 14A—0001104659-26-027106Avanos Medical, Inc.'s most recent proxy was read; its disclosed peer group does not include LivaNova PLC. Filing ↗
120Section 10a, Nevro Corp.(2) reciprocityDEF 14A—0000950170-24-044100Nevro Corp.(2)'s most recent proxy was read; its disclosed peer group does not include LivaNova PLC. Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.

Get the LivaNova PLC Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
LIVN Peer Teardown Report